[Experience with Cosaldon in the treatment of circulatory disorders in the ophthalmological practice].
D001161:Arteriosclerosis / Q000150:complications*; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D009886:Ophthalmoplegia / Q000188:drug therapy; D009900:Optic Nerve / Q000098:blood supply; D012162:Retinal Degeneration / Q000188:drug therapy*; D012171:Retinal Vessels / Q000187:drug effects*; D013805:Theobromine / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000150:complications; D014665:Vasodilator Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014785:Vision, Ocular / Q000187:drug effects
D014665:Vasodilator Agents; D013805:Theobromine
Erfahrungen mit Cosaldon bei der Behandlung von Durchblutungsstörungen in der augenärztlichen Praxis.